fda green list glp-1 launches for safe ingredients, calls for more action | The Partnership for Safe Medicines posted on the topic What's New in Obesity Treatment?

Thyroid Health: We prioritize safety by screening for personal or family history of medullary thyroid carcinoma (MTC) and Multiple Endocrine Neoplasia syndrome type 2 before recommending semaglutide, given its associated risks

10.1089/met.2012.0128 [DOI] [PubMed] [Google Scholar] 160.Maiztegui B, Borelli MI, Madrid VG, Del ZH, Raschia MA, Francini F, et al

The relationship between subclinical thyroid dysfunction and the risk of fracture or low bone mineral density: a systematic review and meta-analysis of cohort studies

In the pool of five placebo-controlled clinical trials in adults, adverse reactions related to volume depletion (e.g., blood pressure (ambulatory) decreased, blood pressure systolic decreased, dehydration, hypotension, hypovolemia, orthostatic hypotension, and syncope) were reported by 0.3%, 0.5%, and 0.3% of patients treated with placebo, JARDIANCE 10 mg, and JARDIANCE 25 mg, respectively

International Journal of Medicinal Chemistry